Karen Sisley
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Karen Sisley has a total of 930 co-authors. Here are the top co-authors by number of shared publications:
- Alexander T.J. Lee
The Christie NHS Foundation Trust, Manchester, United Kingdom
75 shared publications - Avirup Chowdhury
Division of Cancer Biology, The Institute of Cancer Research, London, UK
75 shared publications - Christopher P. Wilding
Division of Molecular Pathology, The Institute of Cancer Research, London, SW3 6JB, UK
75 shared publications - Cyril Fisher
University Hospitals Birmingham NHS Foundation Trust, Birmingham, United Kingdom
75 shared publications - Emma Perkins
Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom
75 shared publications - Jessica Burns
Division of Molecular Pathology, The Institute of Cancer Research, London, United Kingdom
75 shared publications
Latest Publications
- Open Access
- 30 October 2025
- Published by Elsevier in Clinical Surgical Oncology
- Vol. 5 (2)
Surgical interventions improve survival in patients with metastatic uveal melanoma
- 30 October 2025
- Published by Elsevier in Clinical Surgical Oncology
- Vol. 5 (2)
Open AccessSurgical interventions improve survival in patients with metastatic uveal melanoma
- Open Access
- 5 August 2025
- Published by Elsevier in European Journal of Cancer
- Vol. 228, 115687
Uveal Melanoma UK national guidelines: 2023 update
- 5 August 2025
- Published by Elsevier in European Journal of Cancer
- Vol. 228, 115687
Open AccessUveal Melanoma UK national guidelines: 2023 update
- Open Access
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S13 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S13. Summary of univariable (UVA) and multivariable (MVA) Cox regression analyses assessing the association of clinicopathological factors and ssGSEA-derived proteoglycan score with overall survival (OS).
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S13 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S13. Summary of univariable (UVA) and multivariable (MVA) Cox regression analyses assessing the association of clinicopathological factors and ssGSEA-derived proteoglycan score with overall survival (OS).
- Open Access
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S4 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S4: Statistical comparisons between histological subtypes in cluster 1 (C1).
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S4 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S4: Statistical comparisons between histological subtypes in cluster 1 (C1).
- Open Access
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Figure 1 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
The matrisome and adhesome landscape of soft tissue sarcomas (STS). A, Annotated heatmap illustrating the unsupervised clustering (Pearson’s correlation distance) of 302 matrisome and adhesome components in the STS cohort. Top annotation panel correspond to histological subtype. The annotation on the (left) side shows proteins belonging to matrisome or adhesome databases and the breakdown into matrisome and adhesome functional classes. B, Heatmap showing matrisome and adhesome proteins uniquely upregulated (indicated by black boxes) in histological subtypes (false discovery rate <0.01, fold change ≥2), arranged by histological subtype. A selection of matrisome proteins which are upregulated in each histological subtype is shown. AS, angiosarcoma; ASPS, alveolar soft part sarcoma; CCS, clear cell sarcoma; DSRCT, desmoplastic small round cell tumor; ES, epithelioid sarcoma; RT, rhabdoid tumor.
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessFigure 1 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
The matrisome and adhesome landscape of soft tissue sarcomas (STS). A, Annotated heatmap illustrating the unsupervised clustering (Pearson’s correlation distance) of 302 matrisome and adhesome components in the STS cohort. Top annotation panel correspond to histological subtype. The annotation on the (left) side shows proteins belonging to matrisome or adhesome databases and the breakdown into matrisome and adhesome functional classes. B, Heatmap showing matrisome and adhesome proteins uniquely upregulated (indicated by black boxes) in histological subtypes (false discovery rate <0.01, fold change ≥2), arranged by histological subtype. A selection of matrisome proteins which are upregulated in each histological subtype is shown. AS, angiosarcoma; ASPS, alveolar soft part sarcoma; CCS, clear cell sarcoma; DSRCT, desmoplastic small round cell tumor; ES, epithelioid sarcoma; RT, rhabdoid tumor.
- Open Access
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S11 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S11. Statistical association of clinicopathological features with proteoglycan groups.
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S11 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S11. Statistical association of clinicopathological features with proteoglycan groups.
- Open Access
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Table 1 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Clinicopathological characteristics of the cohort.
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessTable 1 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Clinicopathological characteristics of the cohort.
- Open Access
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S2 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S2: Matrisome and adhesome cluster membership.
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S2 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S2: Matrisome and adhesome cluster membership.
- Open Access
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S5 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S5. Summary of multivariable (MVA) analyses assessing association of clinicopathological factors and LCP1 tertiles with local recurrence-free survival (LRFS) and overall survival (OS). Clinicopathological factors which were significantly associated with survival in univariable analyses were included in the MVA model.
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S5 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S5. Summary of multivariable (MVA) analyses assessing association of clinicopathological factors and LCP1 tertiles with local recurrence-free survival (LRFS) and overall survival (OS). Clinicopathological factors which were significantly associated with survival in univariable analyses were included in the MVA model.
- Open Access
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Supplementary Table S7 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S7: Summary of statistical tests to assess the association between clinicopathological features and dedifferentiated liposarcoma (DDLPS) subgroups.
- 30 October 2024
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table S7 from Clinical Implications and Molecular Features of Extracellular Matrix Networks in Soft Tissue Sarcomas
Supplementary Table S7: Summary of statistical tests to assess the association between clinicopathological features and dedifferentiated liposarcoma (DDLPS) subgroups.